Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Woody'S Medical LLC currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action under review at the USPTO. This single pending matter is assigned to 1 distinct examiner and 1 distinct art unit. The concentration of the portfolio in one specific area suggests a concentrated technical focus for the company's current intellectual property strategy.
The busiest examiner for this portfolio is BRAM, STANLEY, who is responsible for 1 busiest examiner pending office action. This examiner handles the 1 pending office action that constitutes the company's entire current pending workload. Practitioners should note that the prosecution experience for this company is presently tied to the specific tendencies of this 1 distinct examiner within the assigned 1 distinct art unit. Because there is only 1 pending office action, the outcome of the company's current prosecution efforts depends entirely on the interaction with this single examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRAM, STANLEY | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18505241 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TESTOSTERONE DEFICIENCY IN MALES | BRAM, STANLEY | 61d |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18505241 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TESTOSTERONE DEFICIENCY IN MALES | BRAM, STANLEY | 1691 | §103 | Non-Final OA | 61d | Pending | Nov 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWoody'S Medical LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stanley Bram has the most, with 1 of Woody'S Medical LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.